Top compounds associated with response to CNTD2


Feature Type Standardized
Nominal ANOVA
mRNA Bortezomib gCSI pan-cancer AAC -0.065 0.3
mRNA MS-275 gCSI pan-cancer AAC -0.051 0.3
mRNA GDC-0941 gCSI pan-cancer AAC 0.019 0.7
mRNA Vorinostat gCSI pan-cancer AAC 0.0057 0.9
mRNA Erlotinib gCSI pan-cancer AAC 0.0029 1
mRNA lapatinib gCSI pan-cancer AAC -0.001 1
Download CSV